TP53 and sarcoma: A somewhat similar approach in cfDNA was adopted by Klega et al. using a hybrid capture bait for a translocation-specific sarcoma sequencing (TranSS-Seq) assay, designed to detect oncogenic gene fusions as well as mutations in common tumor suppressor genes (TP53, STAG2)27.